To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Wi Inc Medical Device Development in Englewood, Colorado, has been Awarded a Contract with SensiVida Medical Technologies
Read time: Less than a minute
Wi Inc. is a MDE award-winning Medical Device design and development company specializing in biologics, therapeutics, and diagnostics design including IVD microfluidic disposables (lab-on-card platforms) and instruments.
Under the agreement, Wi Inc. will provide design and prototype development for the disposable allergen delivery component of the allergy test system. The disposable allergen "cartridge" will provide allergists and other medical professionals the ability to rapidly test patients using up to 40 allergens on small areas of the patient's skin (about one square inch).
In contrast, today's skin prick test is typically performed on all of the patient's back or forearms, and often produces large, uncomfortable reactions or "wheals" that take many hours to dissipate. Early clinical results using SensiVida's disposable allergen cartridge and digital sensing module show that it is totally painless, less invasive, faster, and more accurate than today's tests.
Under the agreement, Wi Inc. will provide design and prototype development for the disposable allergen delivery component of the allergy test system. The disposable allergen "cartridge" will provide allergists and other medical professionals the ability to rapidly test patients using up to 40 allergens on small areas of the patient's skin (about one square inch).
In contrast, today's skin prick test is typically performed on all of the patient's back or forearms, and often produces large, uncomfortable reactions or "wheals" that take many hours to dissipate. Early clinical results using SensiVida's disposable allergen cartridge and digital sensing module show that it is totally painless, less invasive, faster, and more accurate than today's tests.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
